IBDEI141 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19895,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,19895,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,19896,0)
 ;;=780.39^^131^1281^72
 ;;^UTILITY(U,$J,358.3,19896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19896,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,19896,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,19896,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,19897,0)
 ;;=782.0^^131^1281^60
 ;;^UTILITY(U,$J,358.3,19897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19897,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,19897,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,19897,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,19898,0)
 ;;=435.9^^131^1281^74
 ;;^UTILITY(U,$J,358.3,19898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19898,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,19898,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,19898,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,19899,0)
 ;;=354.2^^131^1281^76
 ;;^UTILITY(U,$J,358.3,19899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19899,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,19899,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,19899,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,19900,0)
 ;;=729.1^^131^1281^17
 ;;^UTILITY(U,$J,358.3,19900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19900,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,19900,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,19900,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,19901,0)
 ;;=438.20^^131^1281^6
 ;;^UTILITY(U,$J,358.3,19901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19901,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,19901,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,19901,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,19902,0)
 ;;=438.12^^131^1281^5
 ;;^UTILITY(U,$J,358.3,19902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19902,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,19902,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,19902,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,19903,0)
 ;;=356.8^^131^1281^63
 ;;^UTILITY(U,$J,358.3,19903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19903,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,19903,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,19903,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,19904,0)
 ;;=337.20^^131^1281^68
 ;;^UTILITY(U,$J,358.3,19904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19904,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,19904,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,19904,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,19905,0)
 ;;=294.8^^131^1281^14
 ;;^UTILITY(U,$J,358.3,19905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19905,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,19905,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,19905,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,19906,0)
 ;;=438.6^^131^1281^4
 ;;^UTILITY(U,$J,358.3,19906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19906,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,19906,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,19906,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,19907,0)
 ;;=438.7^^131^1281^7
 ;;^UTILITY(U,$J,358.3,19907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19907,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,19907,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,19907,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,19908,0)
 ;;=438.84^^131^1281^3
 ;;^UTILITY(U,$J,358.3,19908,1,0)
 ;;=^358.31IA^5^2
